Uji klinis Kejang di New Jersey
8 studi untuk Kejang mencari peserta di lokasi di New Jersey.
Kota di New Jersey
Teks studi resmi (Bahasa Inggris)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Tekton Research, Marlboro
Menerima pesertaFase 3
Usia 2 hingga 55 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Hackensack Meridian Neuroscience Institute at JFK University Medical Center, Edison
- Saint Peter's University Hospital, New Brunswick
Menerima pesertaFase 1
Usia 12 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northeast Regional Epilepsy Group - Hackensack, Hackensack
- Hackensack Meridian Health Jersey Shore University Medical Center, Neptune City
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
- Institute of Neurology and Neurosurgery at St. Barnabas, Livingston
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Neurology Center for Epilepsy and Seizures, Marlboro
Menerima pesertaFase 3
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04462770A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT05716100Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Northeast Regional Epilepsy Group, Hackensack
Menerima pesertaFase 3
Usia 4 hingga 55 · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Hackensack
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Apr 2025 · NCT06908356Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.